Cargando…
Adenovirus-based vaccines against avian-origin H5N1 influenza viruses
Since 1997, human infection with avian H5N1, having about 60% mortality, has posed a threat to public health. In this review, we describe the epidemiology of H5N1 transmission, advantages and disadvantages of different influenza vaccine types, and characteristics of adenovirus, finally summarizing a...
Autores principales: | He, Biao, Zheng, Bo-jian, Wang, Qian, Du, Lanying, Jiang, Shibo, Lu, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Institut Pasteur. Published by Elsevier Masson SAS
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110517/ https://www.ncbi.nlm.nih.gov/pubmed/25479556 http://dx.doi.org/10.1016/j.micinf.2014.11.003 |
Ejemplares similares
-
Origin and Characteristics of Internal Genes Affect Infectivity of the Novel Avian-Origin Influenza A (H7N9) Virus
por: Feng, Yan, et al.
Publicado: (2013) -
Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses
por: Hassan, Ahmed O., et al.
Publicado: (2017) -
Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus Vaccines
por: Lin, Shih-Chang, et al.
Publicado: (2011) -
Receptor-binding domain-based subunit vaccines against MERS-CoV
por: Zhang, Naru, et al.
Publicado: (2015) -
Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China
por: Dong, Jinze, et al.
Publicado: (2022)